Guidance for industry : classifying resubmissions in response to action letters.

Bibliographic Details
Corporate Authors:	Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [1998]
Subjects:	Drug approval > United States. User charges > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS118891